These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 12436630)

  • 1. [Clinical trials of restenosis after PTCA and QOL of patients after PTCA].
    Okamoto S; Nakano T
    Nihon Rinsho; 1994 Jul; 52 Suppl(Pt 1):869-73. PubMed ID: 12436630
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prevention of restenosis after PTCA and patient's QOL].
    Okamoto S; Ishisu R; Yamakado T
    Nihon Rinsho; 2003 Apr; 61 Suppl 4():524-8. PubMed ID: 12735027
    [No Abstract]   [Full Text] [Related]  

  • 3. [Prevention of postangioplasty restenosis].
    Kitai T; Ishiwata S; Yamaguchi T
    Nihon Rinsho; 2003 Apr; 61 Suppl 4():627-31. PubMed ID: 12735042
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacologic approaches to restenosis prevention.
    Douglas JS
    Am J Cardiol; 2007 Sep; 100(5A):10K-6K. PubMed ID: 17719348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [New strategies in the treatment of restenosis].
    von Hodenberg E; Tost B; Scheffold T
    Z Kardiol; 2000; 89 Suppl 7():19-22. PubMed ID: 11098555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of cardiovascular events after percutaneous coronary intervention.
    Herrmann HC
    N Engl J Med; 2004 Jun; 350(26):2708-10. PubMed ID: 15215488
    [No Abstract]   [Full Text] [Related]  

  • 7. [Restenosis after PTCA].
    Heidland UE; Michel CJ; Heintzen MP; Strauer BE
    Dtsch Med Wochenschr; 1998 Jul; 123(27):840-6. PubMed ID: 9685844
    [No Abstract]   [Full Text] [Related]  

  • 8. [Modification of re-stenosis with drugs].
    Scheffold T; Müller-Bardorff M; Greten T; von Hodenberg E; Katus HA
    Z Kardiol; 1994; 83 Suppl 4():43-9. PubMed ID: 7856279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prevention of restenosis and of cardiac events after coronary angioplasty in diabetics].
    Nyssen A; Legrand V; Scheen AJ
    Rev Med Suisse; 2009 Aug; 5(214):1638-43. PubMed ID: 19772194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Interaction of statins with clopidogrel].
    Von Scheidt W
    Internist (Berl); 2004 Mar; 45(3):363-5. PubMed ID: 14997315
    [No Abstract]   [Full Text] [Related]  

  • 11. [Incidence of restenosis and cardiac events after coronary angioplasty in diabetic patients: reduction by systemic pharmacological approaches].
    Nyssen A; Legrand V; Scheen AJ
    Rev Med Liege; 2009 Apr; 64(4):192-8. PubMed ID: 19514538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Results of using the resolute stent in everyday clinical practice in 5000 patients].
    Savchenko AP; Rudenko AP; Cherkavskaia OV
    Vestn Rentgenol Radiol; 2010; (4):43-7. PubMed ID: 22187910
    [No Abstract]   [Full Text] [Related]  

  • 13. Optimal medical management of peripheral arterial disease.
    Rice TW; Lumsden AB
    Vasc Endovascular Surg; 2006; 40(4):312-27. PubMed ID: 16959725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological approaches to the prevention of restenosis after coronary angioplasty.
    Hamon M; Lécluse E; Monassier JP; Grollier G; Potier JC
    Drugs Aging; 1998 Oct; 13(4):291-301. PubMed ID: 9805210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimizing percutaneous coronary intervention outcomes: the next steps.
    Vetrovec GW
    Circulation; 2005 Jan; 111(2):125-6. PubMed ID: 15657386
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacological approaches for the prevention of restenosis after percutaneous coronary intervention.
    Lefkovits J; Topol EJ
    Prog Cardiovasc Dis; 1997; 40(2):141-58. PubMed ID: 9327830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Unrecognized myocardial infarction].
    Matsumoto T
    Nihon Rinsho; 2007 Sep; Suppl 5 Pt 2():249-52. PubMed ID: 17952999
    [No Abstract]   [Full Text] [Related]  

  • 18. A randomised determination of the Effect of Fluvastatin and Atorvastatin on top of dual antiplatelet treatment on platelet aggregation after implantation of coronary drug-eluting stents. The EFA-Trial.
    Wenaweser P; Eshtehardi P; Abrecht L; Zwahlen M; Schmidlin K; Windecker S; Meier B; Haeberli A; Hess OM
    Thromb Haemost; 2010 Sep; 104(3):554-62. PubMed ID: 20664903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In-stent late total occlusion following left main coronary artery stenting.
    Canbay A; Ozcan O
    Acta Cardiol; 2008 Oct; 63(5):639-40. PubMed ID: 19014010
    [No Abstract]   [Full Text] [Related]  

  • 20. [Current approaches to restenosis after coronary interventions].
    Magosaki N; Tsurumi Y; Hosoda S
    Nihon Rinsho; 1998 Jan; 56(1):242-8. PubMed ID: 9465696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.